相关实验视频

Updated: Jun 11, 2025

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

向CD47和血管生成证明在膀癌中具有有效的抗瘤作用

Xiting Huang¹, Qian Wang¹, Yanyang Nan¹

¹Department of Biological Medicines and Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai 201203, China.

|September 28, 2024

概括

向CD47显示出通过增强巨细胞活性的膀癌免疫治疗的前景. 将CD47阻断与抗血管生成结合起来,显著改善了抗瘤效应,提供了一个强大的新策略.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
癌症免疫疗法癌症免疫疗法

背景情况:

目前的膀癌免疫疗法反应率有限,需要新的治疗点.
由于CD47在免疫逃避中的作用,因此被探索为膀癌的潜在免疫治疗点.

研究的目的:

评估CD47作为膀癌的治疗点.
研究结合CD47阻断与抗血管生成疗法的疗效.
评估一种针对CD47和血管生成的双特异融合蛋白.

主要方法:

在116个膀癌组织中使用免疫组织化学 (IHC) 评估了CD47蛋白表达.
在体外细胞酶试验中评估了CD47阻断对巨细胞活性的影响.
在体内研究中使用HSPCs-CDX模型来测试CD47阻断,抗血管生成和组合疗法.

主要成果:

CD47在膀癌中表达高,与预后不佳有关.
CD47阻断增强了膀癌细胞的巨细胞化,并显示出抗瘤作用 (TGI: 33.05%).
组合疗法 (CD47阻断+抗血管生成) 显著改善了抗瘤疗效 (TGI: 76.39%),双特异融合蛋白也是如此.

结论:

向CD47促进了膀癌中巨细胞介导的抗瘤免疫力.
结合CD47和血管生成的阻断为膀癌提供了一个强大的免疫疗法策略.
针对这两种途径的双特异融合蛋白显示出显著的抗瘤潜力.

关键词:

通过CD47阻塞疗法治疗CD47阻塞.血管新生的产生.膀癌:膀癌是一种癌症.组合疗法是一种组合疗法.这是先天免疫力.

更多相关视频

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

Published on: July 28, 2012

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.